5 & 6 June 2024
Palexpo, Geneva
Menu Close

Adam Kalbermatten, Vice President of Commercial Development at BD Medical – Pharmaceutical Systems

Adam Kalbermatten leads the BD Pharmaceutical Systems Advanced Drug Delivery Commercial Development Team. Adam is focused on partnering with pharmaceutical and biotechnology companies to provide drug delivery solutions and services that help commercialize drug device combination product therapies. Prior to joining BD, Adam served as Chief Executive Officer of ZebraSci, a combination product contract research and development organization (CRDO) acquired by BD in 2021. Prior to leading the ZebraSci organization, Adam held several leadership roles at Terumo, BD, and Merck. Adam holds a Bachelor of Engineering in Mechanical Engineering and a Master of Engineering in Engineering Management from Stevens Institute of Technology and an MBA from Columbia University.

Discover our group of industry speakers and experts

Register your interest for 2024

Register your interest for 2024 and get updates on when registration opens, as well as speaker and agenda announcements
Register now

Explore the Agenda

Connect in Pharma offers high-quality, technical content, designed in collaboration with world-leading speakers.
see the full agenda